Dray 2008 Neuropathic Pain Emerging Treatments

Lacosamide - Wikipedia
Lacosamide (merknaam: Vimpat van UCB) is een anti-epileptisch geneesmiddel . De Europese Commissie vergunde het middel in de Europese Unie op 29 augustus 2008 . In de Verenigde Staten werd het middel in juni 2009 gelanceerd. Lacosamide werd in de jaren 1990 gesynthetiseerd door de Amerikaanse ... Read Article

Curriculum Vitae - Johns Hopkins University - Department Of ...
Emerging Strategies for the Treatment of Neuropathic Pain, J.N. Campbell, A.I. Basbaum, A. Dray, R. Dubner, R.H. Dworkin and C.N. Sang (Eds) IASP Press, advisor on potential targets for neuropathic pain therapies. 2008 Biogen-Idec, ... Read More

Suffolk Drug & Therapeutics Group
Prescriber/Pharmacy Statement – December 2008, GW Pharmaceuticals. Freynhagen R & Bennett MI. Diagnosis and management of neuropathic pain. British Medical Journal 2009; 339: 391-5. Dray A. Neuropathic pain: emerging treatments. British Journal of Anaesthesia 2008; 101 (1): 48-58. ... View Doc

Sauna - Wikipedia, The Free Encyclopedia
Very often massage and other body and skin treatments are available at the same facilities, either by themselves or in the customer's private room. It is indicated for rheumatic pain (with cold shower) but not for neuropathic pain. Is effective for appetite loss and mild depression. ... Read Article

BooksBooks Available
Treating neuropathic pain and to researchers studying this difficult but important problem. J.N. Campbell, A.I. Basbaum, A. Dray, R. Dubner, R.H. Dworkin, C.N. Sang (Eds). 2006, hardbound volume speaks to core issues integral to emerging pain research and humane health care in the 21st century. ... Doc Viewer

Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain in response to fungal pathogens and hormone treatments a systematic review of evidence (1996-2008) ... Content Retrieval